最新技術レビュー:シアジド利尿剤は,NAPE-PLDを通じてエンドカンナビノイドシステムを利用する
1Laboratori ALIVEDA, Viale Karol Wojtyla 19, 56042 Crespina Lorenzana, Pisa, Italy.
American journal of hypertension
|September 2, 2025
まとめ
エンドカンナビノイド系 (ECS) をターゲットにすることで 高血圧の治療法が生まれます シアジド利尿薬は,無意識にNAPE-PLDを介してECSを標的とし,血管疾患の管理に有効なアプローチを提供します.
科学分野:
- 薬理学について
- 内分泌学
- 心血管医学
背景:
- エンドカンナビノイド系 (ECS) は高血圧や血管疾患の管理のために研究されている.
- カナビノイド受容体1 (CB1) とCB2アゴニスト,およびCB1阻害剤を標的とした以前の試みは,有害な副作用のために課題に直面した.
- 脂肪酸アミドヒドローラゼ (FAAH) 阻害剤は高血圧のネズミの血圧を正常化する有望な効果を示した.
研究 の 目的:
- 高血圧と血管疾患の管理のためのECSをターゲットにする技術の現状を見直す.
- シアジド性尿薬のメカニズムとECSとの関連を解明する.
- 高血圧と血管抵抗の治療におけるECS調節のための新しいアプローチを検証する.
主な方法:
- 心血管疾患に対するECS調節に関する既存の文献のレビュー.
- シアジド利尿剤の標的としての NAPE-PLD の役割に関する調査.
- NAPE-PLDが利尿作用とアナンダミド生成に影響を与えるメカニズムの分析
主要な成果:
- シアジド利尿剤はECSに関連する酵素であるNAPE- PLDを標的とし,ECSの調節に長年の臨床アプローチを示しています.
- NAPE-PLDの活性化により,利尿作用が促進され,慢性高血圧の治療に保護作用を与えるアナンダミドが生成される.
- シアジド結合部位を介してNAPE- PLDを安定させることで高血圧と血管抵抗を効果的に治療します.
結論:
- 60年以上もの間 医者は シアジド性尿薬を使って 意識せずに ECSを標的としたのです
- NAPE-PLDは,高血圧および関連する血管疾患におけるECS調節のための検証された全身標的を表しています.
- NAPE-PLDを安定させる化学薬品は,高血圧に関連した神経血管の変化に対する有望な治療戦略を提供します.
関連する概念動画
Antihypertensive Drugs: Thiazide-Class Diuretics
2.3K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
2.3K
Antihypertensive Drugs: Potassium-Sparing Diuretics
2.6K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.5K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.5K
Opioid Receptors: Overview
7.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.2K
Analgesia and Pain Management
3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K


